About Us
Our Company

Intelligene stands as one of the pioneering drug development companies in Taiwan's biotechnology sector. We are at the forefront of advancing gene therapeutics through siRNA-based drugs, utilizing a revolutionary approach that harnesses the power of RNA interference technology to combat formidable adversaries. Our mission is to confront the looming threats of pandemics and influenza. Our dedicated team of scientists and researchers is united by a shared purpose: to safeguard and improve human well-being by developing innovative solutions. These solutions not only address the immediate challenges posed by infectious diseases but also hold the promise of a healthier future.

Leading innovation in Gene Therapy
Advancing siRNA Therapeutics
Empowering Health of Tomorrow
  • Jerry Huang
    Chairman & CEO

    Education:
    Master of Business Administration from Columbia University, London Business School, and University of Hong Kong

    Experiences:
    Jerry has more than 20 years of experience in public and government relations, investor relations, product marketing, business development and venture capital investment in both biotech and high-tech industries.Before Intelligene Inc., Jerry had a successful track record in turning around two high-tech companies that won contracts awarded by the UK, Singapore, and Taiwan governments. In the biotech industry, Jerry was a part of the team that successfully took two biotech start-up companies to IPO (Lin BioScience in Taiwan and Belite Bio in the US).

    MORE
  • Patty Sung
    President & Chief Operating Officer

    Education:

    • M.A. Biotechnology, Columbia University
    • B.A. Molecular and Cell Biology, emphasis in Biochemistry, UNIVERSITY OF CALIFORNIA, BERKELEY

    Experience:
    Patty is a seasoned entrepreneur with a strong background in the US startup ecosystem. As the former founder and CEO of TAKEUP, she brings extensive experience in building and leading successful ventures. Patty spent over a decade at Mercer, specializing in investment strategies and planning. She played a key role in establishing the Mercer Innovation Hub, where she led initiatives in driving pioneering product development, including patented game-based assessment tools and virtual assistant technology.

     

    MORE
  • Sean Huang
    Chief Finance Officer

    Education:
    Master of Business Administration from Columbia University, London Business School, and University of Hong Kong

    Experiences:
    Sean is a seasoned financial professional with nearly two decades of experience. He has held key leadership roles at CDIB Capital Group and BlackRock Taiwan. Sean's expertise spans international financial markets and includes proficiency in fundraising and asset management. During his time at BlackRock, he led a team managing assets worth nearly $10 billion, establishing the company as a prominent player in the Asia-Pacific region. Sean's track record reflects his strategic prowess and leadership skills in the finance industry.

    MORE
  • Patrick Hafenstein
    Chief Business Development Officer

    Education:
    Bachelor of Arts in Media Production and Asian Studies from Griffith University, Australia

    Experience:
    Before joining Intelligene Inc., Patrick served as Trade and Investment Commissioner at Trade & Investment Queensland (TIQ) in Taipei. Patrick's commitment to bridging international relationships has propelled economic growth and cultural exchange between the two nations. As a fluent speaker of English and Mandarin, he played a pivotal role in transforming the Taipei office into the top-performing investment market and diversifying its focus to include biomedical, renewables, semiconductors, and circular economy sectors.

    MORE